Skip to main content
. 2018 Oct 14;24:7329–7339. doi: 10.12659/MSM.913043

Figure 5.

Figure 5

The prognostic performance of the 3-mRNA signature of liposarcoma. (A) Patient survival status and time distributed by risk score (upper); risk score curve of the 3-mRNA signature (middle); heatmap of 3-mRNA signature from liposarcoma patients (low). (B) The prognostic performance of the risk score shown by the time-dependent receiver operating characteristic (ROC) curve for predicting the 1-, 3-, and 5-year DRFS. (C) The Kaplan-Meier test of the risk score for the overall survival. DRFS – distant recurrence-free survival.